The Hematology Analyzer Market is driven by rising disease prevalence
Key players operating in the hematology analyzer market are Boule Diagnostics AB, Bio-Rad Laboratories, Danaher Corporation, Sysmex, Horiba Medical, Nihon Kohden Corporation, Siemens AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Abbott, Drew Scientific, Diatron, EKF Diagnostics, F. Hoffmann-La Roche Ltd, Cormay Diagnostics, AGD Biomedicals, Pioneer Impex, BIOGENIX INC. PVT. LTD, and Drucker Diagnostics. Sysmex and Abbott hold a significant share in the global hematology analyzer market.
The Global Hematology Analyzer Market Size is expected to witness significant growth due to the rising prevalence of target diseases like anemia, blood cancer, AIDS, and others. As per the WHO, approximately 1.62 billion people, which account for about 24.8% of the world's population, are affected by anemia.
The market is also expanding globally due to the growing investments in healthcare infrastructure from emerging nations. Asia Pacific is emerging as a major hematology analyzer market owing to improving access to healthcare facilities, rising medical tourism, and growing awareness regarding early disease detection in the region.
Explore Our More Blogs on Hematology Analyzer Market
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian